Physician profile
Michael K Layland
NPI 1013917327
$10,251.13
in general payments reported to CMS, 2019-2025
10 companies · $2,294 in 2025
The $2,294 reported for 2025 was more than what 91% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,224 · 2020: $237 · 2021: $445 · 2022: $1,760 · 2023: $981 · 2024: $1,311 · 2025: $2,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,883 · Travel and Lodging: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,883.31 |
| Travel and Lodging | $702.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $5,284.19 | 2019-2025 | Inspire |
| Optinose US, INC. | $3,026.18 | 2019 | |
| Stryker Corporation | $916.28 | 2025 | Scopis Ent |
| Medtronic, INC. | $341.94 | 2022-2025 | Propel |
| Genzyme Corporation | $159.20 | 2024-2025 | |
| Integra Lifesciences Corporation | $146.44 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Olympus America INC. | $141.85 | 2025 | Rhino-Laryngo Videoscope |
| Cochlear Americas | $136.36 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Itamar Medical INC | $77.51 | 2021-2023 | Watchpatone |
| Glaxosmithkline, LLC. | $21.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Layland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.